Nursing Pharmacology: Antiviral Drugs

Nursing Pharmacology: Antiviral Drugs

Antiviral Drugs

Anti-viral drugs with activity against HIV (Human Immunodeficiency Virus)

HIV-1 Pathophysiology/Pathogenesis: HIV Disease Presentations

Renal Dysfunction (continued)

Acute Kidney Injury (AKI)⁵

Factors resulting in acute kidney injury (AKI) noted in patients who are HIV negative are also seen in the HIV-infected population.⁵

For example volume depletion, hypotension, or sepsis can cause acute tubular necrosis and prerenal azotemia.⁵

Acute tubular necrosis damages the renal tubule cells and is a common cause of kidney failure in hospitalized patients.⁶

**Acute Tubular Necrosis⁷**

Riaz S Acute Renal Failure, Slide Share (slide 42 of 86) http://www.slideshare.net/ShahabRiaz/acute-renal-failure-11818845

Opportunistic infections may be treated by nephrotoxic drugs.
Opportunistic infections themselves such as cytomegalovirus (CMV), candida, tuberculosis, histoplasmosis as well as a variety of drugs can result in interstitial nephritis.
- CMV-related pathologies can include nephrocalcinosis.
- Sometimes renal disease may be the presenting indication of HIV infection.
  - Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome is such an example.

Some drugs including acyclovir, atazanavir, indinavir, and sulfadiazine administration may result in crystal-induced obstructive acute kidney injury.⁵
- Indinavir appears associated with asymptomatic crystalluria in as many as 20% of individuals.

Electrolyte abnormalities:

In hospitalized HIV-infected individuals electrolyte abnormalities may be frequently encountered.⁵

For example, up to 30%-50% of hospitalized AIDS patients exhibit hyponatremia.

Up to 20% of hospitalized AIDS patients may exhibit elevated serum potassium i.e. hyperkalemia.

Effects on electrolytes may follow from not only direct consequences of HIV infection but also from opportunistic infections along with drugs used to manage such infections including combination anti-retroviral (cART anti-HIV) medications.

Relationships between abnormal electrolytes and mechanisms in HIV-infected individuals have been described.⁵

Hyponatremia (low serum sodium)⁵
- Volume depletion
- SIADH (Syndrome of inappropriate antidiuretic hormone secretion (Schwartz-Bartter syndrome), secondary to CNS and pulmonary dysfunction.
- Adrenal insufficiency: reduced or absolute adrenal glucocorticoid and/or mineralocorticoid hormones⁹

Hypernatremia⁵

Volume depletion (reduced oral intake)

Acquired nephrogenic diabetes insipidus (medication-induced)

Overview: Diabetes insipidus may be present in patients presenting with polyuria and polydipsia (excessive urination and water ingestion).
- Polyuria may follow from osmotic diuresis induced by glucose, urea, mannitol or diuretics.¹⁰
- Polyuria with the maximally dilute urine are consistent with nephrogenic diabetes insipidus, neurogenic diabetes insipidus and compulsive water ingestion.¹⁰
In the case of neurogenic diabetes insipidus, a pathology involving vasopressin deficiency due to alteration in the hypothalamic-pituitary-axis may be responsible.¹⁰
- Vasopressin (also known as arginine vasopressin (AVP), antidiuretic hormone (ADH) regulates water retention by increasing water absorption in kidney nephron collecting ducts.¹¹
- Vasopressin is a peptide hormone which increases water permeability in the collecting duct (and distal convoluted tubule) by promoting movement of aquaporin (CD, collecting duct)-2 water channels in the kidney nephron collecting duct plasma membrane.¹²
- Nephrogenic diabetes insipidus present as a result of a congenital or acquired pathology.¹⁰
  - For the congenital case, many mutations involving both the vasopressin (V2) receptor or aquaporin-2 water channel have been described.
  - In comparing congenital or acquired forms, the acquired for is notably more common.
    - Examples of acquired nephrogenic diabetes insipidus include:
      - Polycystic kidney disease (PKD)
      - Sickle cell anemia
      - Chronic renal disease
      - Obstructive uropathy¹⁰
  - Drug-induced acquired nephrogenic diabetes insipidus may follow administration of:
    - Lithium
    - Demeclocycline
    - Amphotericin
    - Foscarnet¹⁰

Hyperkalemia⁵
- Hyperkalemia may occur as a consequence of drug administration.
  - Examples of drugs with this effect possibly seen in the HIV-infected population include:
    - Pentamidine
    - Trimethoprim
- Hyporeninemic hypoaldosteronism may also be associated with elevation in K⁺.⁵
  - This disorder may also be described as type IV renal tubular acidosis.¹⁶
    - Hyperkalemia and acidosis present along with typically mild chronic renal disease.
    - The pathophysiology is likely due to reduced renin production by the juxtaglomerular apparatus along with underlying renal pathology.
      - However, the chronic kidney disease component is typically insufficient to account for the observed hyperkalemia.
  - Reduced secretion of both K⁺ and H⁺ in the renal tubule appears responsible for the noted hyperkalemia and metabolic acidosis.¹⁶
- Adrenal insufficiency is another potential cause of hyperkalemia.⁵
  - Adrenal insufficiency in HIV-infected patients is typically associated with advanced disease.¹⁶
    - Opportunistic infections that target the adrenal gland include:
      - Cytomegalovirus (CMV)
      - Disseminated Mycobacterium avium-intracellulare
      - M tuberculosis
      - Cryptococcus neoformans
      - Pneumocystis jiroveci (PCP) as well as
      - Toxoplasma gondii
    - The adrenal gland may also be affected by neoplasms such as Kaposi's sarcoma.¹⁶
  - Clinical adrenal insufficiency is generally uncommon.¹⁶
    - However, more than 50% of individuals with AIDS exhibit necrotizing adrenalitis usually from cytomegalovirus infection.
    - Necrotizing adrenalitis in this setting affects less than about 50%-70% of the adrenal gland; however, adrenal insufficiency requires typically greater than 90% gland destruction.
  - Steroid secretion and metabolism can be altered by medications including ketoconazole which inhibits adrenal and gonadal steroid synthesis.
    - By contrast, rifampin, phenytoin and opioids enhance steroid metabolism.¹⁶

References
Flexner C Antiretroviral Agents and Treatment of HIV Infection, Chapter 59 in Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12th edition (Brunton LL Chabner BA Knollmann BC, eds; Brunton LL, ed; Blumenthal DK Murri N Hilal-Dandan R, assoc eds, Knollmann BC, consulting ed, on-line edition) The McGraw-Hill Companies, 2011. Fauci AS Lane HC Chapter 189, Human Immunodeficiency Virus Disease: AIDS and Related Disorders, in Harrison's Online (Dan L. Longo, Anthony S. Fauci, Dennis L. Kasper, Stephen L. Hauser, J. Larry Jameson, Joseph Loscalzo, Eds.), Harrison's Principles of Internal Medicine, 18th edition, The McGraw-Hill Companies, Inc. 2012. Longo DL Fauci AS 188, The Human Retroviruses, in Harrison's Online (Dan L. Longo, Anthony S. Fauci, Dennis L. Kasper, Stephen L. Hauser, J. Larry Jameson, Joseph Loscalzo, Eds.), Harrison's Principles of Internal Medicine, 18th edition, The McGraw-Hill Companies, Inc. 2012. Woster PM Chapter 43: Antiviral Agents and Protease Inhibitors in Foye's Principles of Medicinal Chemistry 6e, Lemke, TL Williams DA, eds; Roche VG Zito SW, asst eds) Wolters Kluwer\|Lippincott Williams & Wilkins 1214, 2008. Mariani LH Berns JS Chapter 28, Viral Nephropathies in National Kidney Foundation Primer on Kidney Diseasesa 6e (Gilbert SJ Weiner DE, eds) 2014. Acute tubular necrosis MedlinePlus, A service of the U.S. Natinal Library of Medicine (NIH) http://www.nlm.nih.gov/medlineplus/ency/article/000512.htm Riaz S Acute Renal Failure, Slide Share (slide 42 of 86) http://www.slideshare.net/ShahabRiaz/acute-renal-failure-11818845 Nzerue CM Acute Kidney Injury-Update on Pathogenesis, Prognosis and Classification. 2012. https://www.youtube.com/watch?v=BH0R41mK-t0 Hellerstein MC, Endocrine Manifestations of HIV, HIV InSite, http://hivinsite.ucsf.edu/InSite?page=kb-04-01-07#S2.1X Howard C Berl T Chapter 3. Disorders of Water Balance: Hyponatremia & Hypernatremia in Current Diagnosis & Treatment: Nephrology & Hypertension (Lerma EV Berns JS Nissenson AR, eds) The McGraw-Hill Companies, 2009. Caldwell HK Young WS III Oxytocin and Vasopressin: Genetics and Behavioral Implications (In Lajtha A, Lim R Handbook of Neurochemistry and Molecular Neurobiology: Neuroactive Proteins and Peptiddes (3rd ed)) Berlin: Springer pp 573-607. http://refworks.springer.com/mrw/fileadmin/pdf/Neurochemistry/0387303480C25.PDF Nielsen S Chou CL Marples D Christensen EI Kishore BK Knepper MA Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc. Natl. Acad. Sci USA 92: 1013-1017, February 1995. http://www.pnas.org/content/92/4/1013.full.pdf Moeller HB Olesen ETB Fenton RA Regulation of the water channel aquaporin-2 by posttranslational modification. American Journal of Physiology- Renal Physiology 300(5), 1 May 2011. http://ajprenal.physiology.org/content/300/5/F1062 Petri Jr, WA Sulfonamides, Trimethoprim-Sulfamethoxazole, Quinolones, and Agents for Urinary Tract Infections, Chapter 52 in Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12th edition (Brunton LL Chabner BA Knollmann BC, eds; Brunton LL, ed; Blumenthal DK Murri N Hilal-Dandan R, assoc eds, Knollmann BC, consulting ed, on-line edition) The McGraw-Hill Companies, 2011.\ Rosenthal PJ Chapter 52: Antiprotozoal Drugs (in Basic & Clinical Pharmacology, Katzung BG, Trevor AJ) 13 edition, McGraw-Hill Education, 2015. Else T Hammer GD Chapter 21: Disorders of the Adrenal Cortex. in Pathophysiology of Disease, An Introduction to Clinical Medicine (Hmmmer GD, McPhee SJ, eds, 7e) McGraw-Hill Education, 2014, on-line version.

**Disclaimer**
This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information. Medical or other information thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals.